Cipherome Lighthouse Pilot for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stroke+9 MoreCipherome Lighthouse Pilot - DiagnosticTest
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial aims to test whether the use of Cipherome's Lighthouse can improve patient outcomes.

Eligible Conditions
  • Stroke
  • Heart Attack
  • Bleeding
  • Stent Thrombosis
  • Blood Clot

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Study pilot duration is 365 days (1 year)

Year 1
Assessment of the correlation of clinical factors (age, labs, medications) on predicting and preventing adverse drug reactions
Evaluation of aggregate costs
Reduction of major or minor bleeding events
Reduction of treatment failures

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Conventional Therapy (Controls)
1 of 2
Genotype-guided therapy (experimental)
1 of 2

Active Control

Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: Cipherome Lighthouse Pilot · No Placebo Group · N/A

Genotype-guided therapy (experimental)
DiagnosticTest
Experimental Group · 1 Intervention: Cipherome Lighthouse Pilot · Intervention Types: DiagnosticTest
Conventional Therapy (Controls)NoIntervention Group · 1 Intervention: Conventional Therapy (Controls) · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: study pilot duration is 365 days (1 year)

Who is running the clinical trial?

Cipherome, Inc.Lead Sponsor
6 Previous Clinical Trials
915 Total Patients Enrolled
DHR Health Institute for Research and DevelopmentOTHER
10 Previous Clinical Trials
3,336 Total Patients Enrolled
1 Trials studying Stroke
77 Patients Enrolled for Stroke
Yetunde O Kare Opaneye, MDStudy DirectorDHR Health
Herschl Silberman, MDPrincipal InvestigatorDHR Health
Humberto Mochizu Kitamayo, MDStudy DirectorDHR Health

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References